HHLR Advisors’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-273,002
| Closed | -$13.8M | – | 50 |
|
|
2023
Q3 | $13.8M | Hold |
273,002
| – | – | 0.31% | 30 |
|
|
2023
Q2 | $12.7M | Sell |
273,002
-22,500
| -8% | -$1.05M | 0.27% | 33 |
|
|
2023
Q1 | $11.3M | Sell |
295,502
-20,000
| -6% | -$765K | 0.2% | 39 |
|
|
2022
Q4 | $17.3M | Sell |
315,502
-364,498
| -54% | -$20M | 0.37% | 31 |
|
|
2022
Q3 | $23.2M | Sell |
680,000
-679,052
| -50% | -$23.1M | 0.61% | 27 |
|
|
2022
Q2 | $12.8M | Sell |
1,359,052
-100
| -0% | -$945 | 0.28% | 30 |
|
|
2022
Q1 | $19.3M | Hold |
1,359,152
| – | – | 0.4% | 28 |
|
|
2021
Q4 | $28.7M | Sell |
1,359,152
-181,313
| -12% | -$3.83M | 0.44% | 31 |
|
|
2021
Q3 | $34.4M | Sell |
1,540,465
-116,208
| -7% | -$2.6M | 0.45% | 34 |
|
|
2021
Q2 | $41.1M | Hold |
1,656,673
| – | – | 0.42% | 37 |
|
|
2021
Q1 | $48.1M | Hold |
1,656,673
| – | – | 0.47% | 31 |
|
|
2020
Q4 | $42.7M | Hold |
1,656,673
| – | – | 0.34% | 37 |
|
|
2020
Q3 | $51M | Buy |
1,656,673
+600,000
| +57% | +$18.5M | 0.39% | 31 |
|
|
2020
Q2 | $26.3M | Buy |
1,056,673
+165,472
| +19% | +$4.12M | 0.24% | 39 |
|
|
2020
Q1 | $18.9M | Hold |
891,201
| – | – | 0.25% | 37 |
|
|
2019
Q4 | $19.8M | Buy |
891,201
+141,777
| +19% | +$3.15M | 0.25% | 36 |
|
|
2019
Q3 | $17M | Buy |
749,424
+324,424
| +76% | +$7.38M | 0.23% | 44 |
|
|
2019
Q2 | $8.14M | Buy |
+425,000
| New | +$8.14M | 0.18% | 35 |
|